# Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.

> **NCT06995586** · NA · NOT_YET_RECRUITING · sponsor: **Nicosia General Hospital** · enrollment: 108 (estimated)

## Conditions studied

- Cardio-pulmonary Bypass
- Cardiovascular Diseases
- Omega-3 Polyunsaturated Fatty Acids
- Omega-3 Supplementation
- Vitamin C
- Supplements
- Postoperative Depression
- Antioxidants
- Lactulose
- Postoperative
- Optimal Medical Therapy
- CABG
- Coronary Artery Bypass Grafting
- Prebiotics

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin C, Omega 3 PUFA (EPO/DHA), Lignin, Lactulose

## Key facts

- **NCT ID:** NCT06995586
- **Lead sponsor:** Nicosia General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-05-13

## Collaborators

- University of Cyprus
- AVVA Pharmaceuticals Ltd.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06995586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06995586, "Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06995586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*